Therefore, we aimed to begin to understand the pathogenesis of GC among BRCA1 and BRCA2 carriers with the initial primary goal of identifying differences in markers of growth, proliferation, and DNA damage within the gastric epithelium of BRCA1 and BRCA2 carriers, as these factors may contribute to increased GC risk. The gene discussed is BRCA2; the disease is gastric cancer.